Literature DB >> 21057653

The relationship between MECP2 mutation type and health status and service use trajectories over time in a Rett syndrome population.

Deidra Young1, Ami Bebbington, Nick de Klerk, Carol Bower, Lakshmi Nagarajan, Helen Leonard.   

Abstract

This study aimed to investigate the trajectories over time of health status and health service use in Rett syndrome by mutation type. Data were obtained from questionnaires administered over six years to 256 participants from the Australian Rett Syndrome Database. Health status (episodes of illness and medication load) and health service use (general practitioner and specialist visits and hospital stays) were summarized into composite scores with Principal Component Analysis. Linear and mixed regression models examined effects of mutation type and other variables on these scores over time. For some mutations (such as p.R255X, p.R168X) health status was poorer at a younger age and improved over time, while for p.R133C it was better at a younger age and deteriorated with time. For those with p.R133C health service use was lowest at a younger age and highest at 25 years. With other mutations, such as p.R255X, p.R270X, p.R294X, C terminal and p.R306C, health service use was higher at a younger age, but dropped off considerably by 25 years of age. Health service use generally declined in parallel with deterioration in health status, although this pattern differed by mutation type, demonstrating important variability in the course of Rett syndrome.

Entities:  

Year:  2011        PMID: 21057653      PMCID: PMC2968739          DOI: 10.1016/j.rasd.2010.06.007

Source DB:  PubMed          Journal:  Res Autism Spectr Disord


  33 in total

1.  Commentary: three decades of the inverse care law.

Authors:  J Tudor Hart
Journal:  BMJ       Date:  2000-01-01

2.  Describing the phenotype in Rett syndrome using a population database.

Authors:  L Colvin; S Fyfe; S Leonard; T Schiavello; C Ellaway; N De Klerk; J Christodoulou; M Msall; H Leonard
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

3.  Predictors of scoliosis in Rett syndrome.

Authors:  Sarah Ager; Susan Fyfe; John Christodoulou; Peter Jacoby; Lincoln Schmitt; Helen Leonard
Journal:  J Child Neurol       Date:  2006-09       Impact factor: 1.987

4.  Feeding experiences and growth status in a Rett syndrome population.

Authors:  Wendy H Oddy; Kathryn G Webb; Gordon Baikie; Susan M Thompson; Sheena Reilly; Susan D Fyfe; Deidra Young; Alison M Anderson; Helen Leonard
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-11       Impact factor: 2.839

5.  Predictors of seizure onset in Rett syndrome.

Authors:  Le Jian; Lakshmi Nagarajan; Nicholas de Klerk; David Ravine; Carol Bower; Alison Anderson; Sarah Williamson; John Christodoulou; Helen Leonard
Journal:  J Pediatr       Date:  2006-10       Impact factor: 4.406

6.  Is the girl with Rett syndrome normal at birth?

Authors:  H Leonard; C Bower
Journal:  Dev Med Child Neurol       Date:  1998-02       Impact factor: 5.449

7.  Health service use in Rett syndrome.

Authors:  Hannah Moore; Helen Leonard; Nick de Klerk; Ian Robertson; Sue Fyfe; John Christodoulou; Linda Weaving; Mark Davis; Seonaid Mulroy; Lyn Colvin
Journal:  J Child Neurol       Date:  2005-01       Impact factor: 1.987

8.  Survival with Rett syndrome: comparing Rett's original sample with data from the Australian Rett Syndrome Database.

Authors:  Michael Freilinger; Ami Bebbington; Ines Lanator; Nick De Klerk; Daniela Dunkler; Rainer Seidl; Helen Leonard; Gabriel M Ronen
Journal:  Dev Med Child Neurol       Date:  2010-06-22       Impact factor: 5.449

9.  Updating the profile of C-terminal MECP2 deletions in Rett syndrome.

Authors:  A Bebbington; A Percy; J Christodoulou; D Ravine; G Ho; P Jacoby; A Anderson; M Pineda; B Ben Zeev; N Bahi-Buisson; E Smeets; H Leonard
Journal:  J Med Genet       Date:  2009-11-12       Impact factor: 6.318

10.  Gross motor profile in rett syndrome as determined by video analysis.

Authors:  J A Downs; A Bebbington; P Jacoby; M E Msall; O McIlroy; S Fyfe; N Bahi-Buisson; W E Kaufmann; H Leonard
Journal:  Neuropediatrics       Date:  2009-01-22       Impact factor: 1.947

View more
  5 in total

1.  The phenotype associated with a large deletion on MECP2.

Authors:  Ami Bebbington; Jenny Downs; Alan Percy; Mercé Pineda; Bruria Ben Zeev; Nadia Bahi-Buisson; Helen Leonard
Journal:  Eur J Hum Genet       Date:  2012-04-04       Impact factor: 4.246

Review 2.  Clinical and biological progress over 50 years in Rett syndrome.

Authors:  Helen Leonard; Stuart Cobb; Jenny Downs
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

3.  Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model.

Authors:  Sheryl Anne D Vermudez; Rocco G Gogliotti; Bright Arthur; Aditi Buch; Clarissa Morales; Yuta Moxley; Hemangi Rajpal; P Jeffrey Conn; Colleen M Niswender
Journal:  Genes Brain Behav       Date:  2021-05-28       Impact factor: 3.449

4.  Hospitalisation rates for children with intellectual disability or autism born in Western Australia 1983-1999: a population-based cohort study.

Authors:  Ami Bebbington; Emma Glasson; Jenny Bourke; Nicholas de Klerk; Helen Leonard
Journal:  BMJ Open       Date:  2013-02-27       Impact factor: 2.692

5.  Twenty years of surveillance in Rett syndrome: what does this tell us?

Authors:  Alison Anderson; Kingsley Wong; Peter Jacoby; Jenny Downs; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2014-06-19       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.